Terms: = Lung cancer AND CBL, RNF55, 867, ENSG00000110395, C-CBL, CBL2
242 results:
1. Impact of Anti-angiogenic Drugs on Severity of COVID-19 in Patients with Non-Small Cell lung cancer.
Peng S; Huang H; Chen J; Ding X; Zhu X; Liu Y; Chen L; Lu Z
Technol Cancer Res Treat; 2024; 23():15330338241248573. PubMed ID: 38656242
[No Abstract] [Full Text] [Related]
2. Clinical characteristics and MRI based radiomics nomograms can predict iPFS and short-term efficacy of third-generation EGFR-TKI in EGFR-mutated lung adenocarcinoma with brain metastases.
Qi H; Hou Y; Zheng Z; Zheng M; Qiao Q; Wang Z; Sun X; Xing L
BMC Cancer; 2024 Mar; 24(1):362. PubMed ID: 38515096
[TBL] [Abstract] [Full Text] [Related]
3. An Unusual Presentation of Choriocarcinoma in a Postmenopausal Woman: A case report.
Zribi A; Mazroui RA; Sayani R; Burney IA
Sultan Qaboos Univ Med J; 2024 Feb; 24(1):135-138. PubMed ID: 38434469
[TBL] [Abstract] [Full Text] [Related]
4. The incremental healthcare cost associated with cancer in Belgium: A registry-based data analysis.
Gorasso V; Vandevijvere S; Van der Heyden J; Pelgrims I; Hilderink H; Nusselder W; Demoury C; Schmidt M; Vansteelandt S; De Smedt D; Devleesschauwer B
Cancer Med; 2024 Feb; 13(3):e6659. PubMed ID: 38268318
[TBL] [Abstract] [Full Text] [Related]
5. Pembrolizumab monotherapy for non-small cell lung cancer (NSCLC): can patient stratification be improved in the UK Tayside population? A retrospective cohort study.
Mander ES; Merrick CB; Nicholson HA; Lord HK; Ferguson MJ; Smith G
BMJ Open; 2023 Nov; 13(11):e076715. PubMed ID: 37989364
[TBL] [Abstract] [Full Text] [Related]
6. Application of radiomics based on chest CT-enhanced dual-phase imaging in the immunotherapy of non-small cell lung cancer.
Ma ZP; Li XL; Gao K; Zhang TL; Wang HD; Zhao YX
J Xray Sci Technol; 2023; 31(6):1333-1340. PubMed ID: 37840466
[TBL] [Abstract] [Full Text] [Related]
7. Prolonged exposure of environmental concentration benzo[a]pyrene promoted cancer stemness through AhR/PKA/SOX2 dependent pathway in small cell lung cancer.
Ni H; Tang S; Yuan X; Xu J; Zheng F; Chen K; Liu X; Zhang H; Hu J; Xia D; Wu Y
Sci Total Environ; 2024 Jan; 906():167824. PubMed ID: 37839474
[TBL] [Abstract] [Full Text] [Related]
8. lung immune prognostic index‑based nomogram for recurrence of hepatocellular carcinoma after postoperative adjuvant TACE.
Liang Y; Yang R; Shang J; Zhong D; Yang Q; Su Y; Shi Y; Huang X
J Cancer Res Clin Oncol; 2023 Dec; 149(18):16461-16471. PubMed ID: 37707573
[TBL] [Abstract] [Full Text] [Related]
9. [Expert Consensus on Targeted Therapy of NSCLC with MET Exon 14
Skipping Mutation].
Editorial Office of Chinese Journal of Lung Cancer
Zhongguo Fei Ai Za Zhi; 2023 Jun; 26(6):416-428. PubMed ID: 37488079
[TBL] [Abstract] [Full Text] [Related]
10. Transforming properties of MET receptor exon 14 skipping can be recapitulated by loss of the cbl ubiquitin ligase binding site.
Fernandes M; Paget S; Kherrouche Z; Truong MJ; Vinchent A; Meneboo JP; Sebda S; Werkmeister E; Descarpentries C; Figeac M; Cortot AB; Tulasne D
FEBS Lett; 2023 Sep; 597(18):2301-2315. PubMed ID: 37468447
[TBL] [Abstract] [Full Text] [Related]
11. Development of lung cancer risk prediction models based on F-18 FDG PET images.
Choi K; Park JS; Kwon YS; Park SH; Kim HJ; Noh H; Won KS; Song BI; Kim HW
Ann Nucl Med; 2023 Oct; 37(10):572-582. PubMed ID: 37458983
[TBL] [Abstract] [Full Text] [Related]
12. Deep-Learning Model of ResNet Combined with CBAM for Malignant-Benign Pulmonary Nodules Classification on Computed Tomography Images.
Zhang Y; Feng W; Wu Z; Li W; Tao L; Liu X; Zhang F; Gao Y; Huang J; Guo X
Medicina (Kaunas); 2023 Jun; 59(6):. PubMed ID: 37374292
[No Abstract] [Full Text] [Related]
13. CTNNB1 p.D32A (c.95A > C) somatic mutation in stage I grade 1 endometrioid endometrial carcinoma with lung metastasis: a case report.
Zhong L; Jiang W; RutieYin ; Liu H; Song L
BMC Med Genomics; 2023 Jun; 16(1):137. PubMed ID: 37328769
[TBL] [Abstract] [Full Text] [Related]
14. Safety and efficacy of Cesium-131 brachytherapy for brain tumors.
Bander ED; Kelly A; Ma X; Christos PJ; Wernicke AG; Stieg PE; Trichter S; Knisely JPS; Ramakrishna R; Schwartz TH
J Neurooncol; 2023 Jun; 163(2):355-365. PubMed ID: 37249824
[TBL] [Abstract] [Full Text] [Related]
15. Machine Learning Classifier for Preoperative Prediction of Early Recurrence After Bronchial Arterial Chemoembolization Treatment in lung cancer Patients.
Kong C; Lai L; Jin X; Chen W; Ding J; Zheng L; Zhang D; Ying X; Chen X; Chen M; Tu J; Ji J
Acad Radiol; 2023 Dec; 30(12):2880-2893. PubMed ID: 37225529
[TBL] [Abstract] [Full Text] [Related]
16. Sarcopenia and loss of muscle mass in patients with lung cancer undergoing chemotherapy treatment: a systematic review and meta-analysis.
Jensen S; Bloch Z; Quist M; Hansen TTD; Johansen C; Pappot H; Suetta C; Skjødt Rafn B
Acta Oncol; 2023 Mar; 62(3):318-328. PubMed ID: 37051865
[TBL] [Abstract] [Full Text] [Related]
17. Five-year overall survival with ipilimumab and stereotactic ablative radiotherapy for metastatic disease.
He K; Hong DS; Tang C; Sezen D; Cox L; Maleki A; Bertolet G; Nguyen QN; Comeaux NI; Schuda L; Chen D; Welsh JW
Radiother Oncol; 2023 Jun; 183():109618. PubMed ID: 36921766
[TBL] [Abstract] [Full Text] [Related]
18. Acute heart failure presentation, management, and outcomes in cancer patients: a national longitudinal study.
Coles B; Welch CA; Motiwale RS; Teece L; Oliver-Williams C; Weston C; de Belder MA; Lambert PC; Rutherford MJ; Paley L; Kadam UT; Lawson CA; Deanfield J; Peake MD; McDonagh T; Sweeting MJ; Adlam D;
Eur Heart J Acute Cardiovasc Care; 2023 May; 12(5):315-327. PubMed ID: 36888552
[TBL] [Abstract] [Full Text] [Related]
19. Non-occupational physical activity and risk of cardiovascular disease, cancer and mortality outcomes: a dose-response meta-analysis of large prospective studies.
Garcia L; Pearce M; Abbas A; Mok A; Strain T; Ali S; Crippa A; Dempsey PC; Golubic R; Kelly P; Laird Y; McNamara E; Moore S; de Sa TH; Smith AD; Wijndaele K; Woodcock J; Brage S
Br J Sports Med; 2023 Aug; 57(15):979-989. PubMed ID: 36854652
[TBL] [Abstract] [Full Text] [Related]
20. Discovery of potential biomarkers for lung cancer classification based on human proteome microarrays using Stochastic Gradient Boosting approach.
Yao N; Pan J; Chen X; Li P; Li Y; Wang Z; Yao T; Qian L; Yi D; Wu Y
J Cancer Res Clin Oncol; 2023 Aug; 149(10):6803-6812. PubMed ID: 36807761
[TBL] [Abstract] [Full Text] [Related]
[Next]
